🇺🇸 KRYS — Krystal Biotech, Inc.

Salud Compra fuerte
← Volver

Precio actual

305,03 USD

Máx. histórico

378,15

127 días

Caída desde máximo

-19,34%

Rango 52 semanas

192,52 – 382,54

Variación hoy

+3,09%

Cierre anterior

295,90

Rango de hoy

293,26 – 305,43

Volumen hoy

603.048

Peor caída histórica

-53,42%

01/03/2021 → 26/11/2021

Recuperado en 3 días

Volatilidad anualizada ⓘ

73,07%

Información
Nombre completo
Krystal Biotech, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
295
PER ⓘ
41,44 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
393,56 USD (puede no estar actualizado)
Primera cotización
20/09/2017
Precio actualizado
hace 1 día
Sobre la empresa

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/12/2024 194,00 195,82 185,64 185,97 -4,59% 5,24% 295.100
02/12/2024 196,35 198,31 191,78 194,91 -1,27% 3,33% 257.700
29/11/2024 196,56 200,00 195,39 197,42 +0,26% 2,35% 116.600
27/11/2024 197,05 198,87 194,80 196,91 +0,20% 2,06% 139.900
26/11/2024 193,66 196,65 190,56 196,52 +1,01% 3,15% 168.700
25/11/2024 193,69 197,78 193,25 194,56 +2,18% 2,34% 336.300
22/11/2024 184,07 191,27 182,02 190,40 +4,45% 5,02% 222.100
21/11/2024 179,98 183,45 175,09 182,29 +2,35% 4,64% 185.200
20/11/2024 176,60 181,69 173,65 178,10 +0,14% 4,55% 180.600
19/11/2024 174,30 179,00 173,65 177,85 +1,26% 3,07% 215.800
18/11/2024 171,37 176,45 168,88 175,64 +2,87% 4,42% 254.900
15/11/2024 178,36 178,36 169,47 170,74 -3,75% 4,98% 351.100
14/11/2024 183,27 186,44 176,05 177,39 -3,71% 5,67% 275.000
13/11/2024 190,12 192,69 183,62 184,22 -1,60% 4,77% 202.000
12/11/2024 195,77 199,41 186,26 187,22 -4,42% 6,72% 258.500
11/11/2024 202,24 207,84 195,05 195,87 -1,87% 6,32% 296.400
08/11/2024 185,03 200,89 184,86 199,61 +7,64% 8,67% 416.300
07/11/2024 182,26 190,40 182,26 185,45 +1,29% 4,47% 202.500
06/11/2024 184,22 194,59 182,57 183,09 +4,98% 6,52% 610.000
05/11/2024 172,48 175,96 170,65 174,41 +2,08% 3,08% 245.200
04/11/2024 164,85 173,81 163,66 170,85 -3,14% 6,15% 802.900
01/11/2024 173,03 176,49 170,82 176,39 +2,24% 3,28% 296.900
31/10/2024 174,99 175,92 170,09 172,53 -1,71% 3,33% 190.900
30/10/2024 174,81 175,76 172,71 175,53 -0,39% 1,74% 111.900
29/10/2024 175,99 177,23 174,97 176,22 -0,38% 1,28% 85.200
28/10/2024 177,27 180,16 175,71 176,89 +0,79% 2,51% 133.100
25/10/2024 176,62 181,31 175,45 175,51 +0,31% 3,32% 129.200
24/10/2024 173,10 175,12 172,69 174,98 +1,29% 1,40% 115.600
23/10/2024 173,90 174,10 171,69 172,75 -1,40% 1,39% 118.400
22/10/2024 177,64 177,64 174,24 175,20 -2,11% 1,91% 142.900